Biomedical utility of zinc and copper mediated cerium oxide nanoparticles.

Samantha Stoltz, Craig J Neal, Elayaraja Kolanthai, Yifei Fu, Sudipta Seal

Abstract read

In one paragraph

Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Samantha StoltzAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida Orlando Florida USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0009-0002-6677-5979

Craig J NealAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida Orlando Florida USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0001-7288-4229

Elayaraja KolanthaiAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida Orlando Florida USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0003-2615-6866

Yifei FuAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida Orlando Florida USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0001-5271-9031

Sudipta SealAdvanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, Nanoscience Technology Center, Biionix Cluster, College of Medicine, University of Central Florida Orlando Florida USA Sudipta.seal@ucf.edu.ORCID https://orcid.org/0000-0002-0963-3344

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer remains a leading cause of cancer-related death worldwide, motivating the development of nanobiomaterials that exploit tumour-associated redox vulnerabilities while limiting systemic toxicity. Cerium oxide nanoparticles (CeO

Identifiers

PMID42080183

DOI10.1039/d6ra02316a

PMCPMC13130048

What Socratic holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.